Exact Mass: 679.3965

Exact Mass Matches: 679.3965

Found 30 metabolites which its exact mass value is equals to given mass value 679.3965, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Telaprevir

(3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide

C36H53N7O6 (679.4057)


Telaprevir (VX-950) is a highly selective and potent inhibitor of the HCV NS3-4A serine protease. It is a member of a class of antiviral drugs known as protease inhibitors and is the first hepatitis C drug that has demonstrated activity in patients who have failed prior therapy. On April 28, 2011, the FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval telaprevir for people with genotype 1 chronic hepatitis C and was approved in the U.S. in May, 2011. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Nodulisporic acid

5-[7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)


   

Difelikefalin

N-((2R)-1-(((2R)-1-(((2R)-6-Amino-1-(4-amino-4-carboxy-1-piperidinyl)-1-oxo-2-hexanyl)amino)-4-methyl-1-oxo-2-pentanyl)amino)-1-oxo-3-phenyl-2-propanyl)-D-phenylalaninamide

C36H53N7O6 (679.4057)


V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Difelikefalin (CR-845; FE-202845) is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). Difelikefalin produces anti-inflammatory effects and has the potential in modulating pruritus in conditions such as chronic kidney disease[1][2].

   

Nodulisporic acid A

(+)-Nodulisporic acid A

C43H53NO6 (679.3873)


   

Telaprevir (VX-950)

Telaprevir (VX-950)

C36H53N7O6 (679.4057)


   

Telaprevir

(3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide

C36H53N7O6 (679.4057)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

PHDdiA-PE

1-hexadecanoyl-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phosphoethanolamine

C33H62NO11P (679.406)


   

Difelikefalin

Difelikefalin

C36H53N7O6 (679.4057)


V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Difelikefalin (CR-845; FE-202845) is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). Difelikefalin produces anti-inflammatory effects and has the potential in modulating pruritus in conditions such as chronic kidney disease[1][2].

   

(2E,4Z)-5-(7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-prop-1-en-2-yl-21-oxa-1-azaoctacyclo[13.13.1.02,14.03,12.04,9.017,25.018,23.026,29]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl)-2-methylpenta-2,4-dienoic acid

(2E,4Z)-5-(7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-prop-1-en-2-yl-21-oxa-1-azaoctacyclo[13.13.1.02,14.03,12.04,9.017,25.018,23.026,29]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl)-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)


   

(3R,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide

(3R,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide

C36H53N7O6 (679.4057)


   
   

SHexCer 15:1;2O/12:1

SHexCer 15:1;2O/12:1

C33H61NO11S (679.3965)


   
   
   

PE 16:0/12:2;O3

PE 16:0/12:2;O3

C33H62NO11P (679.406)


   
   
   

PS O-20:0/7:2;O2

PS O-20:0/7:2;O2

C33H62NO11P (679.406)


   
   

PS P-18:0/9:1;O2

PS P-18:0/9:1;O2

C33H62NO11P (679.406)


   
   
   
   

IPC 14:2;O2/13:0

IPC 14:2;O2/13:0

C33H62NO11P (679.406)


   

IPC 15:2;O2/12:0

IPC 15:2;O2/12:0

C33H62NO11P (679.406)


   

IPC 16:2;O2/11:0

IPC 16:2;O2/11:0

C33H62NO11P (679.406)


   

IPC 17:2;O2/10:0

IPC 17:2;O2/10:0

C33H62NO11P (679.406)


   
   

ST 28:3;O6;HexNAc

ST 28:3;O6;HexNAc

C36H57NO11 (679.3931)


   

(2e,4e)-5-[(3s,4s,7s,8r,9r,12s,23r,24s,28s)-7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

(2e,4e)-5-[(3s,4s,7s,8r,9r,12s,23r,24s,28s)-7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)